213 related articles for article (PubMed ID: 34610993)
21. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
Kumakech E; Andersson S; Wabinga H; Musubika C; Kirimunda S; Berggren V
BMC Womens Health; 2017 Jun; 17(1):40. PubMed ID: 28576143
[TBL] [Abstract][Full Text] [Related]
22. Risk perception and sexual behavior in HPV-vaccinated and unvaccinated young Colombian women.
Ruiz-Sternberg AM; Pinzón-Rondón ÁM
Int J Gynaecol Obstet; 2014 Sep; 126(3):205-8. PubMed ID: 24996685
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity.
Kudo R; Sekine M; Yamaguchi M; Hara M; Hanley SJB; Kurosawa M; Adachi S; Ueda Y; Miyagi E; Ikeda S; Yagi A; Enomoto T
Cancer Sci; 2022 Sep; 113(9):3211-3220. PubMed ID: 35730321
[TBL] [Abstract][Full Text] [Related]
24. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.
Saccucci M; Franco EL; Ding L; Bernstein DI; Brown D; Kahn JA
Sex Transm Dis; 2018 Apr; 45(4):260-265. PubMed ID: 29465705
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018 : A Cross-sectional Study.
Baussano I; Tshomo U; Tenet V; Heideman DAM; Wangden T; Franceschi S; Clifford GM
Ann Intern Med; 2020 Dec; 173(11):888-894. PubMed ID: 32956600
[TBL] [Abstract][Full Text] [Related]
26. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
27. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study.
Kavanagh K; Pollock KG; Cuschieri K; Palmer T; Cameron RL; Watt C; Bhatia R; Moore C; Cubie H; Cruickshank M; Robertson C
Lancet Infect Dis; 2017 Dec; 17(12):1293-1302. PubMed ID: 28965955
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys.
Sayinzoga F; Tenet V; Heideman DAM; Sibomana H; Umulisa MC; Franceschi S; Hakizimana JD; Clifford GM; Baussano I
Lancet Glob Health; 2023 Jul; 11(7):e1096-e1104. PubMed ID: 37207683
[TBL] [Abstract][Full Text] [Related]
29. Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program.
Khoo SP; Muhammad Ridzuan Tan NA; Rajasuriar R; Nasir NH; Gravitt P; Ng CW; Woo YL
PLoS One; 2022; 17(12):e0278477. PubMed ID: 36538522
[TBL] [Abstract][Full Text] [Related]
30. High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women.
Donken R; King AJ; Bogaards JA; Woestenberg PJ; Meijer CJLM; de Melker HE
J Infect Dis; 2018 Apr; 217(10):1579-1589. PubMed ID: 29409034
[TBL] [Abstract][Full Text] [Related]
31. Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real-world data.
Kurosawa M; Sekine M; Yamaguchi M; Kudo R; Hanley SJB; Hara M; Adachi S; Ueda Y; Miyagi E; Ikeda S; Yagi A; Enomoto T
Cancer Sci; 2022 Apr; 113(4):1435-1440. PubMed ID: 35100477
[TBL] [Abstract][Full Text] [Related]
32. Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes.
Carnalla M; Torres-Ibarra L; Barrientos-Gutiérrez T; Cruz-Valdez A; Muñoz N; Herrero R; Stanley M; Nyitray A; Salmerón J; Lazcano-Ponce E
Vaccine; 2021 Jul; 39(32):4419-4422. PubMed ID: 34183205
[TBL] [Abstract][Full Text] [Related]
33. Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young Women.
Feder MA; Kulasingam SL; Kiviat NB; Mao C; Nelson EJ; Winer RL; Whitham HK; Lin J; Hawes SE
J Womens Health (Larchmt); 2019 Oct; 28(10):1428-1435. PubMed ID: 31264912
[No Abstract] [Full Text] [Related]
34. Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.
Hoes J; Woestenberg PJ; Bogaards JA; King AJ; de Melker HE; Berkhof J; Hoebe CJPA; van der Sande MAB; van Benthem BHB;
Clin Infect Dis; 2021 Mar; 72(5):e103-e111. PubMed ID: 33249475
[TBL] [Abstract][Full Text] [Related]
35. Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis.
Cuschieri K; Kavanagh K; Moore C; Bhatia R; Love J; Pollock KG
Br J Cancer; 2016 May; 114(11):1261-4. PubMed ID: 27115467
[TBL] [Abstract][Full Text] [Related]
36. High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
Sarmiento-Medina MI; de Amaya MP; Villamizar-Gómez L; González-Coba AC; Guzmán-Barajas L
PLoS One; 2024; 19(2):e0297579. PubMed ID: 38315664
[TBL] [Abstract][Full Text] [Related]
37. Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.
Franceschi S; Chantal Umulisa M; Tshomo U; Gheit T; Baussano I; Tenet V; Tshokey T; Gatera M; Ngabo F; Van Damme P; Snijders PJ; Tommasino M; Vorsters A; Clifford GM
Int J Cancer; 2016 Aug; 139(3):518-26. PubMed ID: 26991686
[TBL] [Abstract][Full Text] [Related]
38. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
Demarteau N; Van Kriekinge G; Simon P
Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
[TBL] [Abstract][Full Text] [Related]
39. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.
Man I; Georges D; de Carvalho TM; Ray Saraswati L; Bhandari P; Kataria I; Siddiqui M; Muwonge R; Lucas E; Berkhof J; Sankaranarayanan R; Bogaards JA; Basu P; Baussano I
Lancet Oncol; 2022 Nov; 23(11):1419-1429. PubMed ID: 36174583
[TBL] [Abstract][Full Text] [Related]
40. Detection and Genotyping of HPV DNA in a Group of Unvaccinated Young Women from Colombia: Baseline Measures Prior to Future Monitoring Program.
Puerto D; Reyes V; Lozano C; Buitrago L; Garcia D; Murillo RH; Muñoz N; Hernandez GA; Sanchez L; Wiesner C; Combita AL
Cancer Prev Res (Phila); 2018 Sep; 11(9):581-592. PubMed ID: 29991579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
